Solvent/Detergent Treated Human Plasma from Japan
Human plasma treated with TNBP/Tween 80 to disrupt lipid envelopes of viruses, then purified. Used for transfusion medicine. Classifies as human blood fraction under HTS 3002.12.00.10 despite viral inactivation processing.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Include partition validation studies showing lipid removal post-S/D treatment
• Document dual viral inactivation (S/D + heat) to prevent diagnostic reagent confusion